Pure Global

"Kabi" Aimeco blood component separator - Taiwan Registration 1eac338d8a0bf627cc4aab2343eec17e

Access comprehensive regulatory information for "Kabi" Aimeco blood component separator in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1eac338d8a0bf627cc4aab2343eec17e and manufactured by Fresenius Kabi AG;; PLEXUS MANUFACTURING SDN. BHD.. The authorized representative in Taiwan is FRESENIUS KABI TAIWAN LIMITED.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including FRESENIUS KABI AG;; Fresenius HemoCare GmbH, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
1 Competitors
1 Recent Registrations
1eac338d8a0bf627cc4aab2343eec17e
Registration Details
Taiwan FDA Registration: 1eac338d8a0bf627cc4aab2343eec17e
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Kabi" Aimeco blood component separator
TW: โ€œๅกๆฏ”โ€ๆ„›็พŽๅฏ่ก€ๆถฒๆˆไปฝๅˆ†้›ขๆฉŸ
Risk Class 2

Registration Details

1eac338d8a0bf627cc4aab2343eec17e

DHA05603053701

Company Information

Product Details

For details, it is Chinese approved copy of the imitation order.

B Hematology, pathology, and genetics

B.9245 Automated hemocytoseparator

Input;; Contract manufacturing

Dates and Status

Apr 05, 2018

Apr 05, 2023

Companies Making Similar Products
Top companies providing products similar to ""Kabi" Aimeco blood component separator"